Ober M D, Lemon L C, Shin D H, Nootheti P, Cha S C, Kim P H
Kresge Eye Institute, Wayne State University School of Medicine, Detroit, Michigan 48201-1423, USA.
Ophthalmology. 2000 Oct;107(10):1868-73; discussion 1874. doi: 10.1016/s0161-6420(00)00270-0.
To investigate the long-term outcomes of silicone versus acrylic intraocular lens (IOL) implantation in phacotrabeculectomy (PT) with special emphasis on posterior capsular opacification.
Long-term follow-up on prior 1-year prospective, randomized study.
A total of 200 eyes of 200 consecutive primary open-angle glaucoma patients who had undergone primary PT with capsular bag implantation of either a silicone IOL (102 eyes) or an acrylic IOL (98 eyes) according to the initial short-term prospective, randomized study protocol.
The study eyes underwent primary trabeculectomy, phacoemulsification, and posterior chamber IOL implantation. Adjunctive mitomycin C was used selectively, primarily in patients with one or more risk factors for filtration failure.
Incidence of posterior capsular opacification (PCO), best-corrected visual acuity (BCVA), intraocular pressure (IOP), number of pressure-lowering medications, and filtration success rates, defined as maintenance of target IOP while on one (criteria 1) or zero (criteria 2) pressure-lowering medications without further surgical intervention.
At 3-year follow-up, the PCO rate and BCVA did not differ significantly between the two groups (P: > 0.05 for both). In addition, there were no significant differences in IOP, number of medications, and filtration success rate between the two groups (P: > 0.05 for each).
There were no significant long-term differences between the silicone and acrylic IOL groups in PCO, BCVA, IOP, number of medications, and success of filtration surgery after PT. Both groups attained significant improvement in BCVA and IOP control after surgery.
研究在超声乳化小梁切除术(PT)中植入硅胶人工晶状体与丙烯酸人工晶状体的长期效果,特别关注后囊膜混浊情况。
对先前为期1年的前瞻性随机研究进行长期随访。
根据最初的短期前瞻性随机研究方案,共有200例连续的原发性开角型青光眼患者的200只眼接受了原发性PT并在囊袋内植入了硅胶人工晶状体(102只眼)或丙烯酸人工晶状体(98只眼)。
研究眼接受了原发性小梁切除术、超声乳化术和后房型人工晶状体植入术。选择性使用辅助性丝裂霉素C,主要用于有一项或多项滤过失败危险因素的患者。
后囊膜混浊(PCO)的发生率、最佳矫正视力(BCVA)、眼压(IOP)、降眼压药物数量以及滤过成功率,滤过成功率定义为在使用一种(标准1)或不使用(标准2)降眼压药物且无需进一步手术干预的情况下维持目标眼压。
在3年随访时,两组之间的PCO发生率和BCVA无显著差异(两者P均>0.05)。此外,两组之间在IOP、药物数量和滤过成功率方面也无显著差异(每项P均>0.05)。
PT术后,硅胶人工晶状体组和丙烯酸人工晶状体组在PCO、BCVA、IOP、药物数量和滤过手术成功率方面无显著长期差异。两组术后BCVA和IOP控制均有显著改善。